CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy

Jina Yun, Kyoung-Mee Kim, Seung Tae Kim, Jung-Hoon Kim, Jung A Kim, Jee Hyun Kong, Soo Hyeon Lee, Young-Woong Won, Jong-Mu Sun, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Research and Treatment. 2010;42(2):101-106. Published online 2010 June 30 DOI: https://doi.org/10.4143/crt.2010.42.2.101

Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy

Cancer Research and Treatment. 2010;42(2):101

Link1

Link2

Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy

Zheng Li, Yi Qing, Wei Guan, Mengxia Li, Yu Peng, Shiheng Zhang, Yanli Xiong, Dong Wang

Cancer Chemotherapy and Pharmacology. 2014;74(4):777-786

Link1

Link2 Link3

Predictive value of ERCC1, ERCC2, and XRCC expression for patients with locally advanced or metastatic gastric cancer treated with neoadjuvant FOLFOX chemotherapy

Jaw Yuan Wang

European Journal of Surgical Oncology. 2018;44:S17

Link1 Link2

Predictive value of ERCC1, ERCC2, and XRCC expression for patients with locally advanced or metastatic gastric cancer treated with neoadjuvant FOLFOX chemotherapy

Jaw Yuan Wang

European Journal of Surgical Oncology. 2017;43(11):2216

Link1 Link2

ERCC1, Defective Mismatch Repair Status as Predictive Biomarker of Survival for Stage III Colon Cancer Patients Receiving Oxaliplatin Based Adjuvant Chemotherapy

P. Li, G. Chen

Annals of Oncology. 2012;23:ix180

Link1 Link2

274P ERCC1 expression predicts treatment response and survival in advanced uterine cervical cancer patients treated with platinum-based chemotherapy

S.W. Baek, Y.S. Choi, I.C. Song, H.J. Yun, D.Y. Jo, S.Y. Kim, H.J. Lee

Annals of Oncology. 2015;26:ix80

Link1 Link2

Re: Excision Repair Cross-Complementation Group 1 (ERCC1) Expression in Advanced Urothelial Carcinoma Patients Receiving Cisplatin-Based Chemotherapy

David P. Wood

Journal of Urology. 2011;186(3):842-842

Link1 Link2 Link3

749 POSTER Combination chemotherapy with capecitabine (X) and cisplatin (P) as a first line treatment of advanced gastric cancer: experience of 246 patients with prognostic factor analysis

European Journal of Cancer Supplements. 2005;3(2):214

Link1 Link2

Tubuline, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum–gemcitabine chemotherapy

M. Joerger, D. deJong, A. Burylo, J.A. Burgers, P. Baas, A.D.R. Huitema, J.H. Beijnen, J.H.M. Schellens

Lung Cancer. 2011;74(2):310-317

Link1 Link2

A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy

Chen Chen, Zehua Wang, Yanru Qin

Journal of Inflammation Research. 2023;Volume 16:2929-2946

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.